SCHEMBL1974238

SCHEMBL1974238

CN(C)CCCOc1cccc(S(=O)(=O)n2ccc3ccccc32)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 10/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
HTT P42858 3/20 0.51
ALDH1A1 P00352 2/20 0.51
LMNA P02545 1/20 0.51
HPGD P15428 1/20 0.51
TSHR P16473 1/20 0.51
HTR1A P08908 1/20 0.47
DRD2 P14416 1/20 0.47
HTR1D P28221 1/20 0.47
HTR1B P28222 1/20 0.47
HTR1F P30939 1/20 0.47
HTR7 P34969 1/20 0.47
DRD3 P35462 1/20 0.47
MET P08581 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.46
POLB P06746 1/20 0.46
KDM4E B2RXH2 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1972514 0.94 HTR6 (0.52) HTR6MEN1KMT2AHTTALDH1A1
SCHEMBL1976660 0.87 HTR6 (0.61) HTR6MEN1KMT2AHTR1ADRD2
SCHEMBL1972675 0.87 HTR6 (0.50) HTR6ALDH1A1HTR1ADRD2HTR1D
SCHEMBL1971474 0.87 ALDH1A1 (0.47) HTR6MEN1KMT2AHTTALDH1A1
SCHEMBL1972785 0.83 HTR6 (0.50) HTR6MEN1KMT2AHTTALDH1A1
SCHEMBL1971891 0.82 HTR6 (0.56) HTR6HTR1ADRD2HTR1DHTR1B
SCHEMBL1973097 0.82 HTR6 (0.63) HTR6MEN1KMT2AHTR1ADRD2
SCHEMBL1972338 0.82 HTR6 (0.48) HTR6MEN1KMT2AHTTALDH1A1
SCHEMBL1976662 0.80 HTR6 (0.47) HTR6MEN1KMT2AHTTALDH1A1
SCHEMBL25455094 0.80 HTR6 (0.66) HTR6MEN1KMT2AHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003670-B2 Aminoalkoxy aryl sulfonamide compounds and their use as 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2011-08-23 US claimed
EP-2155674-B1 AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LTD (IN) 2011-06-22 EP claimed
US-20100087484-A1 AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2010-04-08 US claimed
US-8003670-B2 Aminoalkoxy aryl sulfonamide compounds and their use as 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2011-08-23 US disclosed
US-20100087484-A1 AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2010-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087484-A1 AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS HTR6, HTR5A, HTR1B HTR6 1/4885MEN1 2457/4885KMT2A 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.